Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C1-inhibitor in Allergic Asthma Patients
NCT03051698Phase 4Terminated
- Sponsor
- Tom van der Poll
- Start
- Nov 2016
- Primary completion
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of c1-esterase inhibitor in asthma, sponsored by Tom van der Poll. Started Nov 2016; status: terminated.
02
Drugs
c1-esterase inhibitor
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03051698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03051698.